Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten Derlin

Showing results (181-190 of 192) with videos related to

Pageof 20
Sort By:
Frontiers in Oncology|May 27, 2021
Combining <sup>68</sup>Ga-PSMA-PET/CT-Directed and Elective Radiation Therapy Improves Outcome in Oligorecurrent Prostate Cancer: A Retrospective Multicenter StudySimon Kirste, Stephanie G C Kroeze, Christoph Henkenberens, et al.
The Prostate|January 12, 2023
Lack of repeatability of radiomic features derived from PET scans: Results from a <sup>18</sup> F-DCFPyL test-retest cohortRudolf A Werner, Bilêl Habacha, Susanne Lütje, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2019
Validation of different PSMA-PET/CT-based contouring techniques for intraprostatic tumor definition using histopathology as standard of referenceConstantinos Zamboglou, Thomas F Fassbender, Lina Steffan, et al.
BMC Cancer|May 1, 2020
Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapyAnn-Kathrin Oehus, Stephanie G C Kroeze, Nina-Sophie Schmidt-Hegemann, et al.
Molecular Imaging|March 14, 2022
High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with <sup>18</sup>F-DCFPyLRudolf A Werner, Bilêl Habacha, Susanne Lütje, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 31, 2020
Intraprostatic Tumor Segmentation on PSMA PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural NetworkDejan Kostyszyn, Tobias Fechter, Nico Bartl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 15, 2025
The German Cancer Consortium (DKTK) multi-center prospective phase 1/2 <sup>68</sup>Ga-PSMA-11 PET-imaging trial in newly-diagnosed high-risk prostate cancer: Safety and diagnostic accuracy compared to histopathology and their impact on patient managementFrederik L Giesel, Stefan A Koerber, Boris Hadaschik, et al.
Nature Reviews. Cardiology|June 5, 2023
Clinical quantitative coronary artery stenosis and coronary atherosclerosis imaging: a Consensus Statement from the Quantitative Cardiovascular Imaging Study GroupAldo J Vázquez Mézquita, Federico Biavati, Volkmar Falk, et al.
Frontiers in Cardiovascular Medicine|April 25, 2020
Comparison of MRI and VQ-SPECT as a Screening Test for Patients With Suspected CTEPH: CHANGE-MRI Study Design and RationaleFlorian Lasch, Annika Karch, Armin Koch, et al.
Nuklearmedizin. Nuclear Medicine|July 14, 2021
Value of PET imaging for radiation therapyConstantin Lapa, Ursula Nestle, Nathalie L Albert, et al.
Pageof 20

Showing results (181-190 of 192) with videos related to

Sort By:
Pageof 20
Frontiers in Oncology|May 27, 2021
Combining <sup>68</sup>Ga-PSMA-PET/CT-Directed and Elective Radiation Therapy Improves Outcome in Oligorecurrent Prostate Cancer: A Retrospective Multicenter StudySimon Kirste, Stephanie G C Kroeze, Christoph Henkenberens, et al.
The Prostate|January 12, 2023
Lack of repeatability of radiomic features derived from PET scans: Results from a <sup>18</sup> F-DCFPyL test-retest cohortRudolf A Werner, Bilêl Habacha, Susanne Lütje, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2019
Validation of different PSMA-PET/CT-based contouring techniques for intraprostatic tumor definition using histopathology as standard of referenceConstantinos Zamboglou, Thomas F Fassbender, Lina Steffan, et al.
BMC Cancer|May 1, 2020
Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapyAnn-Kathrin Oehus, Stephanie G C Kroeze, Nina-Sophie Schmidt-Hegemann, et al.
Molecular Imaging|March 14, 2022
High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with <sup>18</sup>F-DCFPyLRudolf A Werner, Bilêl Habacha, Susanne Lütje, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 31, 2020
Intraprostatic Tumor Segmentation on PSMA PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural NetworkDejan Kostyszyn, Tobias Fechter, Nico Bartl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 15, 2025
The German Cancer Consortium (DKTK) multi-center prospective phase 1/2 <sup>68</sup>Ga-PSMA-11 PET-imaging trial in newly-diagnosed high-risk prostate cancer: Safety and diagnostic accuracy compared to histopathology and their impact on patient managementFrederik L Giesel, Stefan A Koerber, Boris Hadaschik, et al.
Nature Reviews. Cardiology|June 5, 2023
Clinical quantitative coronary artery stenosis and coronary atherosclerosis imaging: a Consensus Statement from the Quantitative Cardiovascular Imaging Study GroupAldo J Vázquez Mézquita, Federico Biavati, Volkmar Falk, et al.
Frontiers in Cardiovascular Medicine|April 25, 2020
Comparison of MRI and VQ-SPECT as a Screening Test for Patients With Suspected CTEPH: CHANGE-MRI Study Design and RationaleFlorian Lasch, Annika Karch, Armin Koch, et al.
Nuklearmedizin. Nuclear Medicine|July 14, 2021
Value of PET imaging for radiation therapyConstantin Lapa, Ursula Nestle, Nathalie L Albert, et al.
Pageof 20